Announced Wed, 12 Nov · 19:15 IST

Submission of Monitoring Agency Report issued by ICRA Limited for the quarter ended September 30, 2025.

ENTERO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Entero Healthcare Solutions has filed the quarterly Monitoring Agency Report prepared by ICRA Limited with the stock exchanges. This report is a SEBI-mandated compliance requirement, typically applicable to companies that have raised funds through an IPO or qualified institutional placement. ICRA, acting as the independent Monitoring Agency, reviews and certifies how the company is deploying the money raised from public/institutional investors. The filing covers the quarter ending September 30, 2025. The actual content of the report, including any deviations or observations about fund usage, would be detailed in the report attached to this filing.

Likely market impact

This is a routine regulatory compliance filing and is unlikely to have any direct impact on the stock price. Investors should review the attached ICRA report to check for any deviations in the use of proceeds from what was originally stated at the time of fundraise.